Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2025
A Fighter Bigger Than MyelomaAdeel M KhanHematology (Amsterdam, Netherlands)|October 23, 2013
BCR-ABL inhibitors: updates in the management of patients with chronic-phase chronic myeloid leukemiaAdeel M Khan, Dale L BixbyBritish Journal of Haematology|February 24, 2026
Resumption of bone-modifying agents in relapsed multiple myeloma does not improve outcomes: A real-world analysisMalcolm Su, Adeel M Khan, Andrew J Cowan, et al.Precision Cancer Medicine|August 11, 2020
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?Kartik Sehgal, Andrew J Piper-Vallillo, Hollis Viray, et al.Journal of Thrombosis and Haemostasis : JTH|September 7, 2021
Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosisThita Chiasakul, Robert Redd, Rushad Patell, et al.Plos Medicine|May 25, 2022
Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort studyAdeel M Khan, Thita Chiasakul, Robert Redd, et al.Blood Cancer Journal|March 23, 2024
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysisFieke W Hoff, Rahul Banerjee, Adeel M Khan, et al.Blood Cancer Journal|March 29, 2025
Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysisSharlene Dong, Rahul Banerjee, Adeel M Khan, et al.JCO Oncology Practice|October 17, 2024
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin LymphomasNaveen Premnath, Yulun Liu, Heather Reves, et al.Pageof 1